AHRQ 30% FY 2003 Budget Increase To Be Urged By Friends Of Agency
This article was originally published in The Gray Sheet
Executive Summary
The Friends of the Agency for Healthcare Research and Quality plans to recommend an allocation of at least $390 mil. for the agency in support of AHRQ's role as an independent entity with purview over health services research
You may also be interested in...
FDA Centralization Plan Under Review; HHS Aiming For “One Clear Message”
Consolidation of HHS public affairs and legislative activities across the department will blunt the political impact of the incoming FDA commissioner, potentially allowing the position to focus on science policy and product review issues
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.